-
1
المؤلفون: Bonnie Vlahos, Gaston Solano, J Abraham Simón-Campos, Cecilia Borlenghi, Generoso Guerra Bautista, Ricardo Machado Xavier, Maria de la Vega, Ronald Pedersen
المصدر: Open Access Rheumatology : Research and Reviews
مصطلحات موضوعية: rheumatoid arthritis, musculoskeletal diseases, medicine.medical_specialty, clinical outcome, predictor, patient-reported outcome, Etanercept, Research and Reviews [Open Access Rheumatology], 03 medical and health sciences, 0302 clinical medicine, Patient satisfaction, Rheumatology, immune system diseases, Internal medicine, Post-hoc analysis, medicine, In patient, 030212 general & internal medicine, skin and connective tissue diseases, Original Research, 030203 arthritis & rheumatology, business.industry, medicine.disease, Rheumatoid arthritis, Methotrexate, Patient-reported outcome, business, etanercept, medicine.drug
وصف الملف: text/html
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c78b6a9938d8e637d7457c579e511b0Test
https://doi.org/10.2147/oarrr.s228866Test -
2
المؤلفون: Soumya D. Chakravarty, Jessica A. Walsh, Timothy Fitzgerald, Qian Cai, Christopher D Pericone, I. Lin
المصدر: Current Medical Research and Opinion. 36:1245-1252
مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, 030204 cardiovascular system & hematology, Biologic treatment, Injections, Etanercept, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, medicine, Adalimumab, Humans, 030212 general & internal medicine, Certolizumab pegol, skin and connective tissue diseases, Aged, Retrospective Studies, business.industry, Arthritis, Psoriatic, Biologic therapies, General Medicine, Middle Aged, medicine.disease, Dermatology, humanities, Golimumab, Biological Therapy, Antirheumatic Agents, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2f4a4768f802422710387a253ecf66eTest
https://doi.org/10.1080/03007995.2020.1754186Test -
3
المؤلفون: Amanda Teeple, Erik Muser, Bingcao Wu, Steven R. Feldman, Christopher D Pericone
المصدر: Journal of Dermatological Treatment. 32:595-602
مصطلحات موضوعية: Adult, musculoskeletal diseases, medicine.medical_specialty, Population, macromolecular substances, Dermatology, Etanercept, Medication Adherence, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Psoriasis, Internal medicine, Ustekinumab, medicine, Adalimumab, Humans, skin and connective tissue diseases, education, Retrospective Studies, 030203 arthritis & rheumatology, education.field_of_study, business.industry, Middle Aged, medicine.disease, Discontinuation, Treatment Adherence and Compliance, Secukinumab, Apremilast, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e5fc8cdffd619ec8aefbe6632212b5Test
https://doi.org/10.1080/09546634.2019.1687828Test -
4
المؤلفون: Alberto Costantini, Alessia Romagnoli, Fiorenzo Santoleri
المصدر: Expert Opinion on Drug Safety. 19:93-97
مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Adolescent, 030204 cardiovascular system & hematology, Etanercept, Medication Adherence, Persistence (computer science), Young Adult, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Internal medicine, Adalimumab, medicine, Humans, Pharmacology (medical), In patient, Hospital pharmacy, skin and connective tissue diseases, Aged, Retrospective Studies, Aged, 80 and over, National health, business.industry, Arthritis, Psoriatic, General Medicine, Middle Aged, medicine.disease, Antirheumatic Agents, 030220 oncology & carcinogenesis, Female, Observational study, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7259c7ce1ccde8f075597f356caafe88Test
https://doi.org/10.1080/14740338.2020.1681396Test -
5
المصدر: Current Medical Research and Opinion. 35:2197-2205
مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Adipokine, 030204 cardiovascular system & hematology, Severity of Illness Index, Etanercept, Arthritis, Rheumatoid, 03 medical and health sciences, Joint disease, 0302 clinical medicine, Insulin resistance, Adipokines, Internal medicine, medicine, Humans, In patient, 030212 general & internal medicine, business.industry, Adalimumab, Antibodies, Monoclonal, Lipid metabolism, General Medicine, Middle Aged, Lipid Metabolism, medicine.disease, Infliximab, Treatment Outcome, Endocrinology, Anti tnf α, Rheumatoid arthritis, Female, Tumor Necrosis Factor Inhibitors, Tumor necrosis factor alpha, Insulin Resistance, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::217cc336ab60deea031456613e4f3732Test
https://doi.org/10.1080/03007995.2019.1654988Test -
6
المؤلفون: Alessandro Giollo, John Fitton, Maya H Buch
المصدر: Fitton, J, Giollo, A & Buch, M H 2018, ' GP2015 as a promising therapy for rheumatoid arthritis ', Expert opinion on biological therapy, vol. 18, no. 4, pp. 477-481 . https://doi.org/10.1080/14712598.2018.1452909Test
مصطلحات موضوعية: musculoskeletal diseases, Drug, medicine.medical_specialty, Receptors, Tumor Necrosis Factor/genetics, medicine.medical_treatment, media_common.quotation_subject, Clinical Biochemistry, Antibodies, Anti-Idiotypic/blood, Lymphotoxin-alpha/immunology, Receptors, Tumor Necrosis Factor, Etanercept, Arthritis, Rheumatoid, Double blind, 03 medical and health sciences, 0302 clinical medicine, Etanercept/adverse effects, Drug Discovery, medicine, Humans, Dermatologic Agents/adverse effects, skin and connective tissue diseases, Intensive care medicine, Biosimilar Pharmaceuticals, Lymphotoxin-alpha, media_common, 030203 arthritis & rheumatology, Pharmacology, Clinical Trials as Topic, Tumor Necrosis Factor-alpha, business.industry, Biosimilar, Tumor Necrosis Factor-alpha/immunology, medicine.disease, Reference drug, Antibodies, Anti-Idiotypic, TNF inhibitor, Arthritis, Rheumatoid/drug therapy, 030220 oncology & carcinogenesis, Rheumatoid arthritis, Pharmacodynamics, Biosimilar Pharmaceuticals/adverse effects, Dermatologic Agents, business, Half-Life, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc10b8a5e28ee9b2b92b7ca93635614fTest
https://doi.org/10.1080/14712598.2018.1452909Test -
7
المؤلفون: Man R Shim
المصدر: Open Access Rheumatology: Research and Reviews. 11:173-177
مصطلحات موضوعية: musculoskeletal diseases, 030203 arthritis & rheumatology, medicine.medical_specialty, Ankylosing spondylitis, Axial skeleton, business.industry, medicine.disease, Etanercept, Clinical trial, 03 medical and health sciences, 0302 clinical medicine, Total spinal, medicine.anatomical_structure, Rheumatology, Internal medicine, Medicine, Lumbar spine, Tumor necrosis factor alpha, 030212 general & internal medicine, business, Adverse effect, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ba2334cf217dca2f1a13e0217708eff8Test
https://doi.org/10.2147/oarrr.s212456Test -
8
المؤلفون: Juliana Alvares Teodoro, Alessandra Maciel Almeida, Augusto Afonso Guerra Junior, Francisco de Assis Acurcio, Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos
المصدر: Expert Review of Clinical Immunology. 15:879-887
مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Immunology, Etanercept, Medication Adherence, Cohort Studies, Psoriatic arthritis, Indirect costs, Internal medicine, Epidemiology, medicine, Adalimumab, Humans, Immunology and Allergy, Proportional Hazards Models, Tumor Necrosis Factor-alpha, business.industry, Proportional hazards model, Arthritis, Psoriatic, Middle Aged, medicine.disease, Infliximab, Biological Therapy, Antirheumatic Agents, Medication Persistence, Costs and Cost Analysis, Female, business, Brazil, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bfbe768090b532fc56e7ae9b6bde554Test
https://doi.org/10.1080/1744666x.2019.1631798Test -
9
المؤلفون: Mehdi Yaseri, Maryam Sahebari, M Mahmoodi, Hojjat Zeraati, Mohammad Ali Mansournia, Saeed Akhlaghi
المصدر: Pragmatic and Observational Research. 10:23-28
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, business.industry, Confounding, Marginal structural model, medicine.disease, Gastroenterology, Infliximab, Etanercept, Rheumatoid arthritis, Internal medicine, Propensity score matching, medicine, Methotrexate, business, Survival rate, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1f86cb47a565bff0c0eefc938ea98ff8Test
https://doi.org/10.2147/por.s194408Test -
10
المؤلفون: Mehdi Yaseri, Maryam Sahebari, Hojjat Zeraati, Houshang Rafatpanah, Saeed Akhlaghi, M Mahmoodi, Mohammad Ali Mansournia
المصدر: Therapeutics and Clinical Risk Management
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, longitudinal, Therapeutics and Clinical Risk Management, ALT, MTX, Gastroenterology, DMARDs, Transaminase, Etanercept, 03 medical and health sciences, 0302 clinical medicine, immune system diseases, Internal medicine, medicine, Pharmacology (medical), 030212 general & internal medicine, General Pharmacology, Toxicology and Pharmaceutics, skin and connective tissue diseases, AST, Original Research, 030203 arthritis & rheumatology, Chemical Health and Safety, medicine.diagnostic_test, business.industry, Incidence (epidemiology), General Medicine, medicine.disease, Infliximab, Rheumatoid arthritis, Elevated transaminases, Methotrexate, biologic DMARDs, business, Liver function tests, Safety Research, medicine.drug
وصف الملف: text/html
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f39f4fc8b133d98f90602cc4660c331fTest
https://doi.org/10.2147/tcrm.s172836Test